Concepedia

Roslyn Dillon

RD

Statistics

Publications

8

Citations

219

H-Index

8

Active since

2008

Affiliations

Abterra Biosciences (United States)(Current)

Pfizer (United States)

University of Copenhagen

Hvidovre Hospital

Thermo Fisher Scientific (United States)

Roslyn Dillon is an author at Abterra Biosciences (United States) specializing in oncology, medicine, and colorectal cancer.

Publications per year

2008–2018

8

Publications

8

Quantitative Phosphoproteomic Analysis of the STAT3/IL-6/HIF1α Signaling Network: An Initial Study in GSC11 Glioblastoma Stem Cells

Carol L. Nilsson, Roslyn Dillon, Arugadoss Devakumar et al. · Journal of Proteome Research · 2009 · 96 citations

, , +17

A Plasma-Based Protein Marker Panel for Colorectal Cancer Detection Identified by Multiplex Targeted Mass Spectrometry

Jeffrey J. Jones, Bruce E. Wilcox, Ryan W. Benz et al. · Clinical Colorectal Cancer · 2016 · 35 citations · Full text

, , +17

Discovery of a Novel B-Raf Fusion Protein Related to c-Met Drug Resistance

Roslyn Dillon, Stone D.‐H. Shi, Nathan V. Lee et al. · Journal of Proteome Research · 2011 · 20 citations

, , +17

A large-scale and robust dynamic MRM study of colorectal cancer biomarkers

Jia You, Athit Kao, Roslyn Dillon et al. · Journal of Proteomics · 2018 · 16 citations

, , +14

Development of a novel LC/MS method to quantitate cellular stearoyl-CoA desaturase activity

Roslyn Dillon, Michael J. Greig, Balkrishen Bhat · Analytica Chimica Acta · 2008 · 14 citations

, , +13

1–5 of 8